Suppr超能文献

铁螯合中的性别差异

Sex and Gender Differences in Iron Chelation.

作者信息

Allegra Sarah, Comità Stefano, Roetto Antonella, De Francia Silvia

机构信息

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga University Hospital, 10043 Orbassano, Italy.

出版信息

Biomedicines. 2024 Dec 18;12(12):2885. doi: 10.3390/biomedicines12122885.

Abstract

BACKGROUND/OBJECTIVES: In the absence of physiological mechanisms to excrete excessive iron, the administration of iron chelation therapy is necessary. Age and hormones have an impact on the absorption, distribution, metabolism, and excretion of the medications used to treat iron excess, resulting in notable sex- and gender-related variances.

METHODS

Here, we aimed to review the literature on sex and gender in iron overload assessment and treatment.

RESULTS

The development of iron chelators has shown to be a successful therapy for lowering the body's iron levels and averting the tissue damage and organ failure that follows. Numerous studies have described how individual factors can impact chelation treatment, potentially impact therapeutic response, and/or result in inadequate chelation or elevated toxicity; however, most of these data have not considered male and female patients as different groups, and particularly, the effect of hormonal variations in women have never been considered.

CONCLUSIONS

An effective iron chelation treatment should take into account sex and gender differences.

摘要

背景/目的:由于缺乏排泄过量铁的生理机制,因此有必要进行铁螯合治疗。年龄和激素会影响用于治疗铁过量的药物的吸收、分布、代谢和排泄,从而导致明显的性别差异。

方法

在此,我们旨在综述关于铁过载评估和治疗中性别方面的文献。

结果

铁螯合剂的研发已被证明是一种成功的疗法,可降低体内铁水平,并避免随之而来的组织损伤和器官衰竭。许多研究描述了个体因素如何影响螯合治疗、潜在影响治疗反应,和/或导致螯合不足或毒性升高;然而,这些数据大多未将男性和女性患者视为不同群体,特别是从未考虑过女性激素变化的影响。

结论

有效的铁螯合治疗应考虑性别差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ff4/11673655/423059b92579/biomedicines-12-02885-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验